Jack Golabek Appointed as CEO of AIM

https://www.aim.ca/wp-content/uploads/i-a-acquisition-e1517855596515.jpg 400 400 Artificial Intelligence in Medicine Inc. Artificial Intelligence in Medicine Inc. https://www.aim.ca/wp-content/uploads/i-a-acquisition-e1517855596515.jpg February 5, 2018 January 8, 2019

With the acquisition of Artificial Intelligence In Medicine, Inc. (AIM) by Inspirata Holdings, Inc. USA, Jack Golabek has succeeded Dr. Peter Brueckner as Chief Executive Officer on February 1st, 2018. Peter started AIM in 1983 and his leadership, skill and vision have driven the company to its success. Jack has presided over AIM’s engineering activities for 24 years and looks forward to guiding AIM on the road ahead.

Click here for a word from Peter Brueckner, founder & former CEO of AIM.

Jack Golabek Appointed as CEO of AIM

AIM Signs Contract with the National Cancer Institute (NCI) to Use E-Path Reporter for Reporting by U.S. Central Cancer Registries

Inspirata Holdings, Inc. Acquires AIM

AIM Welcomes Manager of Operations and Delivery to the Team!

Type Here